Patient Capital Management’s CVS Health CVS Stock Holding History

Patient Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$97.5M	Buy	1,357,159 +125,743	+10%	+$9.69M	3.56%	13
2025 Q4	$97.7M	Sell	1,231,416 -8,478	-0.7%	-$668K	3.77%	10
2025 Q3	$93.5M	Sell	1,239,894 -2,030	-0.2%	-$139K	3.74%	10
2025 Q2	$85.7M	Sell	1,241,924 -83,714	-6%	-$5.49M	3.87%	9
2025 Q1	$89.8M	Buy	1,325,638 +27,209	+2%	+$1.63M	4.62%	7
2024 Q4	$58.3M	Buy	1,298,429 +529,333	+69%	+$29.7M	2.69%	21
2024 Q3	$48.4M	Buy	769,096 +29,387	+4%	+$1.71M	2.37%	21
2024 Q2	$43.7M	Buy	739,709 +167,135	+29%	+$10.5M	2.32%	21
2024 Q1	$45.7M	Sell	572,574 -28,403	-5%	-$2.17M	2.22%	23
2023 Q4	$47.5M	Sell	600,977 -4,143	-0.7%	-$295K	2.51%	15
2023 Q3	$42.2M	Buy	+605,120	New	+$42.9M	2.48%	20

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Patient Capital Management's CVS Position: Q1 2026 in Review

Patient Capital Management increased its CVS Health (CVS) stake by 10% in Q1 2026, buying an estimated $9.69M and bringing the position to 1,357,159 shares worth $97.5M. The position accounts for 3.56% of the portfolio, ranked #13.

Patient Capital Management first reported a position in CVS in Q3 2023 and has held it in 11 quarters since. The position peaked at $97.7M in Q4 2025. 1,872 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Patient Capital Management held 1,357,159 shares of CVS Health worth $97.5M as of Q1 2026.
Patient Capital Management bought 125,743 CVS Health shares in Q1 2026, an estimated $9.69M.
CVS Health made up 3.56% of Patient Capital Management's portfolio in Q1 2026, its #13 holding.
Patient Capital Management first reported a position in CVS Health in Q3 2023 and has held it in 11 quarters since.
Patient Capital Management's CVS Health position peaked at $97.7M in Q4 2025.
1,872 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Patient Capital Management's 13F filing for Q1 2026, filed 14 May 2026.